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Abstract: Oral mucosa as the front-line barrier in the mouth is constantly exposed to a complex
microenvironment with multitudinous microbes. In this study, the interactions of mesoporous silica
nanoparticles (MSNs) with primary human gingival epithelial cells were analyzed for up to 72 h,
and their diffusion capacity in the reconstructed human gingival epithelia (RHGE) and porcine ear
skin models was further assessed at 24 h. It was found that the synthesized fluorescent mesoporous
silica nanoparticles (RITC-NPs) with low cytotoxicity could be uptaken, degraded, and/or excreted
by the human gingival epithelial cells. Moreover, the RITC-NPs penetrated into the stratum corneum
of RHGE in a time-dependent manner, while they were unable to get across the barrier of stratum
corneum in the porcine ear skins. Consequently, the penetration and accumulation of RITC-NPs
at the corneum layers of epithelia could form a “nanocoating-like barrier”. This preliminary
proof-of-concept study suggests the feasibility of developing nanoparticle-based antimicrobial and
anti-inflammatory agents through topical application for oral healthcare.
Keywords: nanoparticles; human gingival epithelium; coating; stratum corneum
1. Introduction
In recent years, nanotechnology has gained great attention and been increasingly applied to
different disciplines in healthcare. The inorganic mesoporous silica nanoparticles (MSNs) have been
extensively studied and further developed into various cutting-edge technologies for bio-imaging,
cancer therapy, drug delivery, and solid supports of molecular or supramolecular switches owing
to their unique features [1–3]. Plenty of in vivo studies have investigated their bio-distribution,
accumulation, and clearance in certain tissues via intravenous injection [4–6]. However, there is
still no consensus on the bio-safety of nanomaterials [7]. Comparing with intravenous injection,
topical application could enhance the safety of nanomaterials by keeping them away from the
circulation at a certain level [8]. Thereby, the critical concerns of the accumulation of nanomaterials
in the targeting tissues or organs should be addressed carefully. As such, further understanding on
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the delicate interactions of these nanoparticles with normal epithelia cells is crucial for assessing the
potential risks of their applications in topical medications.
It is well noted that porcine ear skin as a valid in vitro model could provide convincing results
with human skin in transdermal study due to their structural similarity and comparable biochemical
properties [9]. Meanwhile, oral mucosa containing both keratinized and non-keratinized epithelia
can be stratified as the epidermis of skin [10]. Gingival epithelia consisting of both keratinized oral
epithelia and non-keratinized sulcular epithelia are on the front line of innate host response to microbial
challenge, and critically account for periodontal health. Gingival niche is indeed a critical target for
the delivery of anti-infective and -inflammatory agents in tackling one of the most common diseases
in humans, i.e. the periodontal (gum) disease. Previous studies have compared the differences in
the permeability of water and nicotine across oral mucosa and skin [11–13]. However, it remains
unclear on the exact diffusion capacity of nanoparticles in the oral mucosa, as well as the potential
difference in the penetration of nanomaterials in oral mucosa and skin. Hence, based on our recent
work [14], we synthesized the fluorescent mesoporous silica nanoparticles (RITC-NPs), analyzed their
interactions with the primary human gingival epithelial cells (hGECs), and subsequently evaluated
their penetration efficiency in two representative epithelial structures of the reconstructed human
gingival epithelia (RHGE) and porcine ear skin models.
2. Results
The scanning electron microscope (SEM) images showed that the fabricated MSNs and RITC-NPs
presented shapes from spheres to ellipsoids (Figure 1a,b). The average size and Zeta potential of
RITC-NPs were 271.9 ± 171.2 nm and 18.49 mv, respectively (Figure 1c). Under UV excitation,
the RITC-NPs emitted an obvious red fluorescence (Figure S1). Their cytotoxicity was evaluated
on the hGECs using Cell Counting Kit-8. Notably, the RITC-NPs exhibited less cytotoxicity on the cells
with reference to the bare MSNs at the same concentration (200 µg/mL) (Figure 1d), probably due to
the enlarged nanoparticle size after surface modification and fluorescent labeling [15].
Next, the fluorescent images showed that the RITC-NPs could be internalized by the hGECs at 24 h
(Figure 2b). After incubation in the nanoparticle-free medium for another 24 and 48 h, small amounts
of RITC-NPs remained in the cells (Figure 2c,d). As common fluorescent dyes with stable performance
in the acidic and enzymatic environment, rhodamine B and its derivatives have been developed as
fluorescent probes for lysosomal labeling and tracking [16]. Notably, it has been confirmed that silica
nanoparticles can be degraded intracellularly [17] and released by cells [18], which could account
for the observation of the decrease of fluorescence intensity in the cells (Figure 2c,d and Figure 3).
Our observations were consistent with previous findings on the internalization and expulsion of
MSNs in mammal cells [18–20]. However, most of these studies were conducted on cancer cell lines
or phagocytic cells, and they varied greatly in cellular activities and functions with normal primary
cells [21]. Taken together, our current findings suggest that the fabricated MSNs with low cytotoxicity
could be internalized and intracellularly degraded and/or released by the primary human gingival
epithelial cells. Further study is required to clarify this point. The epithelial penetration efficiency of
RITC-NPs was examined on two representative epithelial structures, i.e., isolated porcine ear skin and
RHGE that have a histological structure similar to human gingiva (Figure S2a) [22]. Interestingly, the
RITC-NPs penetrated into the stratum corneum of RHGE in a time-dependent manner (Figure 4a–h).
After 2 h treatment, only light red fluorescence dots and lines were visualized on the top of stratum
corneum layer in the RHGE (Figure 4c,d), and the fluorescence intensity increased at 6 h (Figure 4e,f)
and markedly enhanced at 24 h (Figure 4g,h). Surprisingly, no fluorescent signal was detected at the
deeper layers of RHGE after 24 h treatment, suggesting the penetration and accumulation of RITC-NPs
within the corneum layer of RHGE. However, the penetration profile of RITC-NPs was to some extent
different in the porcine ear skin model. The fluorescent light was visible at 2 h, and it became more
obvious at 6 h (Figure 4k–n). However, no obvious fluorescence nanoparticles were detected beyond
the stratum corneum even after 24 h treatment, as it could act as a natural epithelial barrier and repel
the RITC-NPs (Figure 4o,p). In addition, the hair follicles in the porcine ear skin provided other routes
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for the accumulation of RITC-NPs, whereas they were not able to critically go across the follicular
barrier into the underlying dermis (Figure S3). This finding supports the notion that hair follicles could
be a potential target of the nanomaterials-based drug delivery vehicles [23]. Overall, a fairly even
penetration and distribution of nanoparticles in the corneum layer were observed in the two selected
epithelial structures, following 24 h treatment of RITC-NPs in the RHGE and porcine ear skin.
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Figure 1. Field emission scanning electron microscope (FE-SEM) images of the mesoporous silica
nanoparticles (MSNs) (a) and synthesized fluorescent mesoporous silica nanoparticles (RITC-NPs) (b),
and the size distribution of RITC-NPs analyzed by dynamic light scattering (DLS) (c). The viability of
human gingival epithelial cells (hGECs) after 24 h treatment with various concentrations of MSNs and
RITC-NPs was assessed using the Cell Counting Kit-8 (CCK-8) by measuring the absorbance (450 nm)
of the supernatant (d). Three independent experiments were undertaken in triplicate. The asterisk (*)
indicates the significant difference (p < 0.05) between the control and treatment groups.
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Figure 2. Fluorescent images of the hGECs incubated with the RITC-NPs for 0 h as the control (a) and
24 h (b). The cells were further incubated in the nanoparticle-free medium for another 24 h (c) and
48 h (d). The cell nucl i and cytosk letal F-actin fibers were fluorescently stained with blue and green,
respectively. The red fluorescence represents RITC-NPs.
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another 24 and 48 h incubation in the nanoparticle-free media. Error bars represent the standard
deviation of three replicates.
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Figure 4. The merged fluorescent images and red fluorescent channels of RITC-NPs in the reconstructed
human gingival epithelia (RHGE) at 0 (a,b), 2 (c,d), 6 (e,f) and 24 h (g,h) as well as the porcine ear
skin at 0 (i,j), 2 (k,l), 6 (m,n) and 24 h (o,p). The blue and red fluorescence reflects the cell nuclei and
RITC-NPs, respectively. Scale bars: 40 µm in RHGE images and 20 µm in porcine ear skin images.
3. Discussion
Porcine ear skin as a well-established in vitro model has been frequently used to test
the penetration capacity of different nanomaterials, such as carbon nanotubes, quantum dots,
and polystyrene nanoparticles [24,25]. Although silica nanoparticles have been investigated in different
cell models, there are a limited number of studies on their penetration and permeation through skins.
Generally, silica nanoparticles with an average size less than 25 nm can penetrate but could not
permeate the skin [24]. As the vehicles of quercetin, MSNs with an average size of 250 nm can facilitate
drug penetration in the skin while without transdermal delivery [26]. This could be due to the barrier
property of stratum corneum. Moreover, the silica nanoparticles with a diameter of 42 nm were found
to be present around the epidermal cells through topical allocation, owing to partial disruption of
the stratum corneum of human skin explants [27]. Our findings enhance the possible role of barrier
property of stratum corneum in response to the nanoparticle penetration.
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Oral mucosa as the front-line barrier is constantly exposed to a complex and dynamic
microenvironment with multitudinous microbes. Periodontal disease is one of the most common
oral diseases and major health burdens globally, and it results from dental plaque biofilms-induced,
dysregulated immuno-inflammatory response [28,29]. Human gingiva is “armed” by a cluster of innate
defense molecules through dynamic interactions with microbes [30]. Therefore, effective control of
plaque biofilms and gingival inflammation is crucial for periodontal health [31]. In the present study,
it was found that MSNs with low cytotoxicity could penetrate while accumulate predominantly in the
stratum corneum of the RHGE after 24 h treatment. As such, a form of “nanocoating-like barrier” could
be generated along the superficial layers of the epithelia. It is noted that the human gingival epithelia
constantly maintain self-renewal via detaching aged corneum layers and the regulated movement of
keratinized gingival epithelial cells toward the superficial layers [10].
4. Materials and Methods
4.1. Reagents
The chemicals including cetyltrimethylammonium bromide (CTAB), 3-aminopropyltriethoxy
silane (APTES), and rhodamine B isothiocyanate (RITC) were obtained from Sigma-Aldrich (St. Louis,
MO, USA), and tetraethyl orthosilicate (TEOS) as the silica source was purchased from Acros Organics
(Thermo Fisher Scientific, Waltham, MA, USA). Aqueous ammonia and 37% hydrochloric acid were
ordered from VWR (Radnor, PA, USA) and RCI Labscan (Bangkok, Thailand), respectively.
4.2. Fabrication and Characterization of Fluorescence-Labeled MSNs
The nanoparticles were synthesized and surface-modified according to our recent report [14].
Briefly, 0.36 g of CTAB were dissolved in 180 mL of distilled water at 30 ◦C to obtain the clear
solution. An amount of 5 mL of aqueous ammonia was subsequently added into the solution as
a catalyst. TEOS (1.56 mL) was suspended in 10 mL of ethanol, and the suspension was then dropped
into the solution at 1 mL/min and stirred for 5 h at room temperature. After 24 h, the MSNs were
collected following centrifugation (6000 rpm for 10 min) using a centrifuge (5804, Eppendorf, Hamburg,
Germany). The surfactant was removed by sonication twice in acidic ethanol for further usage. To graft
the amine functional groups on the MSNs, 0.5 g of MSNs were dispersed in 100 mL of ethanol and
refluxed with 1.25 mL APTES overnight. The amine-modified MSNs (APTES-NPs) were subsequently
harvested by centrifugation. After being washed with ethanol twice, 0.2 g of the oven-dried APTES-NPs
were dispersed in a sealed RITC ethanol solution (0.125 mg/mL, 40 mL) with magnetic stirring for 4 h
at room temperature. The fluorescence-labeled MSNs were collected by centrifugation followed by
ethanol washing twice. The MSNs and RITC-NPs were properly dried in vacuum, and the morphology
was analyzed via LEO1530 field emission scanning microscopy (FE-SEM, Zeiss, Oberkochen, Germany)
and SU8010 FE-SEM (Hitachi, Tokyo, Japan), respectively. The average size and Zeta potential of the
RITC-NPs were analyzed by Nanotrac Wave (Microtrac, San Diego, CA, USA). The fluorescence of
RITC-NPs was excited using UV light and visualized by naked eyes.
4.3. Cell Culture and Viability Assay
The hGECs were purchased from CellnTec Advanced Cell Systems AG (Bern, Switzerland),
and cultured in a CnT-24 medium with supplements (CellnTec) and 1% penicillin. The cells
were cultured at 37 ◦C with 5% CO2 in the humidified incubator. After reaching the confluence,
the 3rd passage of hGECs was seeded in a 96-well plate at a density of 2 × 104 cells/well and
subsequently treated with the MSNs or RITC-NPs at various concentrations (200, 100, 50, 25,
and 12.5 µg/mL) for 24 h. The cell viabilities were assessed by the Cell Counting Kit-8 (Sigma-Aldrich,
St. Louis, MO, USA). In brief, 100 µL of the medium in each well were discarded, and 10 µL of CCK-8
solution were then added and incubated for 2 h. The absorbance of the media was measured at 450 nm
by a microplate reader (SpectraMax M2, Molecular Devices, Sunnyvale, CA, USA).
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4.4. The Internalizations of RITC-NPs with hGECs
The hGECs at 4th passage (2 × 104 cells/well) were cultured in 16-well glass slides (NuncTM
Lab-TekTM II Chamber SlideTM System, Thermo Scientific, Waltham, MA, USA), and treated with
50 µg/mL of RITC-NPs for 24 h. Then, the medium was removed, and the cells were washed gently
with phosphate buffered saline (PBS) twice. The cells were subsequently fixed with 3.7% formaldehyde
for 10 min at room temperature and then stained with Alexa Fluor® 488 Phalloidin. After the staining,
the cells were washed again with the PBS. The gasket of the slide was removed, and the cells were
mounted with a Fluoro-Gel II mounting medium containing DAPI (Electron Microscopy Sciences,
Hatfield, PA, USA) and covered by the coverslips. The interaction of RITC-NPs with the cells were
visualized by an Olympus 1× 2-UCB fluorescent microscope (Tokyo, Japan). The fluorescence intensity
of RITC-NPs in the cells was examined according to the methods described by Harush-Frenkel and
co-workers with some modifications [32]. In order to assess the amount of the RITC-NPs in the hGECs,
the cells were seeded at a density of 2 × 104 cells/well in 96-well plates and treated with the RITC-NPs
(50 µg/mL) for 24 h. The media were removed, and the cells were washed gently with the PBS
twice. A fresh blank medium was added to the cells and changed every 24 h. At each time point,
the fluorescence intensity of the RITC-NPs in the cells was determined by the Microplate Reader
(SpectraMax M2, Molecular Devices, Sunnyvale, CA, USA) with excitation and emission wavelengths
of 543 and 580 nm, respectively.
4.5. Preparation and Characterization of the Porcine Ear Skin and Reconstructed Human Gingival Epithelia
Porcine ears were obtained from a local market after the pigs were freshly sacrificed. The ear
skin was carefully removed from the underlying cartilage using a scalpel and was then incubated
in Dulbecco’s PBS (Thermo Fisher, Waltham, MA, USA) at 37 ◦C for the permeability experiment.
The reconstructed human gingival epithelia (RHGE) were purchased from the Episkin (Nice, France)
and cultured in the SkinEthic maintenance medium (Episkin, Nice, France) on inert polycarbonate
filters (0.5 cm2) at 37 ◦C in a humidified incubator with 5% CO2. Both porcine ear skin and RHGE were
processed in formalin, dehydrated, and embedded in paraffin for histological staining.
4.6. Penetration Tests of the RITC-NPs
An area of the porcine ear skin was cut out using surgical scissors according to the shape and size
of the contact point on the Franz diffusion cells (17 mL, Red & Blue Medicine Technical Equipment,
Nanjing, China). It was then placed in a sandwiched way such that the epithelial portion faced
the donor compartment and the underlying connective tissues toward the receiver compartment.
The dispersion of RITC-NPs (200 µg/mL) was prepared via sonication in PBS for 10 min and then
added to the donor compartment. The incubation was carried out at 37 ◦C using the Automatic
Transdermal Apparatus (TP-6, Red & Blue Medicine Technical Equipment, Nanjing, China). The tissues
were harvested at 0, 2, 6, and 24 h, and the surfaces were washed with PBS twice to remove the loosely
adhered RITC-NP. Subsequently, the tissues were fixed in 4% paraformaldehyde and dehydrated
in a gradient sucrose solution (10%, 20% and 30%). They were embedded in a Tissue-Tek O.C.T.
compound (Sakura Finetek, VWR, Radnor, PA, USA) for cryosection. On arrival, the RHGE were
immediately removed from the agarose gel and placed carefully onto 6-well plates containing 1 mL of
a maintenance medium for incubation overnight. Well-dispersed RITC-NPs at 200 µg/mL were added
to the RHGE topically. They were incubated for 0, 2, 6, and 24 h and then harvested with PBS washing.
The samples were fixed in 4% paraformaldehyde, dehydrated, and embedded in an O.C.T. compound
for cryosection. All cryosections were mounted with a Fluoro-Gel II mounting medium containing
DAPI (Electron Microscopy Sciences, Hatfield, PA, USA) and observed under an Olympus 1 × 2-UCB
fluorescent microscope (Tokyo, Japan).
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4.7. Statistical Analysis
The significant difference between the testing and control groups was analyzed by a one-way
ANOVA using GraphPad Prism 6.
5. Conclusions
The present findings show the observable profiles of the interactions of fluorescent silica
nanoparticles with primary gingival epithelial cells, and their notable penetration and accumulation
at the superficial corneum layers of epithelia. This preliminary proof-of-concept study strongly
suggests the feasibility of developing MSN-based anti-infective and anti-inflammatory agents in
topical applications for effective oral healthcare.
Supplementary Materials: The following are available online at www.mdpi.com/2079-4991/6/11/192/s1.
Acknowledgments: This work was supported by the General Research Fund (GRF) from the Hong Kong Research
Grants Council (HKU767512 to Lijian Jin and HKBU201213 to Ken Cham-Fai Leung) and the Modern Dental
Laboratory/HKU Endowment Fund to Lijian Jin. We thank Xinmiao Lan from The University of Hong Kong,
Elaine Wat, and Clara Bik San Lau from The Chinese University of Hong Kong for their technical support.
Author Contributions: Xuan Li, Ken Cham-Fai Leung, and Lijian Jin conceived and designed the experiments;
Xuan Li, Ka Yan Pang and Tsz Wing Ng performed the experiments; Xuan Li, Ping Chung Leung, Cheng Fei Zhang,
Ken Cham-Fai Leung and Lijian Jin analyzed the data; Ping Chung Leung, Ken Cham-Fai Leung and Lijian Jin
contributed reagents/materials/analysis tools; Xuan Li, Ken Cham-Fai Leung and Lijian Jin wrote the paper.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
The following abbreviations are used in this manuscript:
MSNs mesoporous silica nanoparticles
hGECs human gingival epithelial cells
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RITC-NPs fluorescent mesoporous silica nanoparticles
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